CellCentric

News

CellCentric has raised $220 million in a Series D financing that will help fund pivotal trials of p300/CBP inhibitor inobrodib in multiple myeloma.

News

Germany's government is reportedly scrapping plans to introduce a controversial system of variable rebates on medicines.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.